Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Dan Mogren
Tag: Dan Mogren
CLS receives order from ClearPoint Neuro
9 January, 2024
CLS strengthens its position in the US
30 November, 2023
CLS looks forward to further expansion
21 November, 2023
CLS starts new clinical study in prostate cancer
9 November, 2023
CLS CEO on Q2 and upcoming milestones
28 August, 2023
CLS on a Q3 characterised by US-advancement
23 November, 2022
ClearPoint Neuro delivers first order to CLS
21 October, 2022
BioStock Studio: CLS about the FDA clearance
3 October, 2022
Accelerated clinical trials and launch of new products for CLS
4 August, 2022
CLS enters 2022 raring to go
18 January, 2022
1
2
Page 1 of 2
